Vyvanse still scarce

TGA may have been premature in declaring supply shortages of Vyvanse are “resolved”, a pharmacist says  Securing supplies of various strengths of ADHA medication, Vyvanse (lisdexamfetamine dimesilate) is continuing to challenge pharmacists despite the Therapeutic Goods Administration (TGA) declaring that shortages have been “resolved”.  Capital Chemist Group general manager, Andrew Topp, told the AJP that

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Notice on newsletter dates
Next Keeping up with credentialing